1. 5 A novel microRNA signature associated with cisplatin resistant NSCLC holds both diagnostic and prognostic biomarker potential. (January 2016) Authors: MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; Young, V.; Ryan, R.; Nicholson, S.; Leonard, N.; Yin Sui, J. Sze; O'Byrne, K.J.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 6 Cisplatin induces the emergence and expansion of a distinct cancer stem cell (CSC) population in NSCLC. (January 2016) Authors: MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; Young, V.; Ryan, R.; Nicholson, S.; Leonard, N.; O'Byrne, K.J.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 7 Cancer stem cells: targeting aldehyde dehydrogenase 1 (ALDH1) as a novel strategy to overcome cisplatin resistance in NSCLC. (January 2016) Authors: MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; O'Byrne, K.J.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 8 Exploitation of the vitamin A/retinoic acid axis in the re-sensitisation of cisplatin resistant NSCLC cells. (January 2016) Authors: MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; O'Byrne, K.J.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗